Supplementary Figure 2 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401503.v1

2023-01-01

Abstract:Activation and cytotoxicity of NK cells by interaction with BCSCs or non-BCSCs.

What problem does this paper attempt to address?

Supplementary Figure 3 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401497

2023-01-01

Abstract:Preferential evasion of BCSCs from NK cell clearance in vivo.
Supplementary Figure 6 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401488

2023-01-01

Abstract:Suppression of MICA/B by overexpressing miR-20a in BCSCs.
Supplementary Figure 7 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401485.v1

2023-01-01

Abstract:The effect of ATRA on the sensitivity to NK cell killing, survival, and lung metastasis of BCSCs
Supplementary Figure 5 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401491.v1

2023-01-01

Abstract:Knockdown of MICA or MICB in non-BCSCs.
Supplementary Figure 1 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401506

2023-01-01

Abstract:Characterization of stem-like properties of ALDH+ cells isolated from primary breast cancer specimens.
Supplementary Text from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401479.v1

2023-01-01

Abstract:Supplementary Text including Supplementary Methods and Supplementary Figure Legends
Supplementary Figure S2 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Linlin Yan,Mingming Wu,Tianyu Wang,Hui Yuan,Xiao Zhang,Huafeng Zhang,Tao Li,Vijay Pandey,Xinghua Han,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.25731645

2024-01-01

Abstract:Supplementary Figure S2 shows that BCSC CM enhances the aerobic glycolysis not oxidative phosphorylation.
Supplementary Tables 1 - 10 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401482

2023-01-01

Abstract:Table S1. The levels of ALDH1+ cells and CD56+ cells and the clinical parameters of breast cancers. Table S2. Univariate analysis of potential prognostic factors for the ALDH1low and ALDH1high subgroups of breast cancers. Table S3. Multivariate analysis of potential prognostic factors for the ALDH1low and ALDH1high subgroups of breast cancers. Table S4. Patient characteristics of primary breast cancers for culture. Table S5. Antibodies used in the study. Table S6. Primers used for cloning coding sequence of MICA and MICB. Table S7. Primers sequences that were used in the qRT-PCR. Table S8. Small interference RNA sequences for knockdown of MICA and MICB expression. Table S9. Primers used for cloning of MICA-3â€™UTR and MICB-3â€™UTR. Table S10. Nucleotide sequences of MICA-3â€™UTR and MICB-3â€™UTR with mutant binding sites for miRNA-20a.
Supplementary Figure S4 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Linlin Yan,Mingming Wu,Tianyu Wang,Hui Yuan,Xiao Zhang,Huafeng Zhang,Tao Li,Vijay Pandey,Xinghua Han,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.25731639

2024-01-01

Abstract:Supplementary Figure S4 shows that MIF secreted by BCSCs to enhance the glycolysis of breast cancer cells.
Supplementary Figures 1 Through 7, Supplementary Methods from Immune Escape in Breast Cancer During in Situ to Invasive Carcinoma Transition

Carlos R. Gil Del Alcazar,Sung Jin Huh,Muhammad B. Ekram,Anne Trinh,Lin L. Liu,Francisco Beca,Xiaoyuan Zi,Minsuk Kwak,Helga Bergholtz,Ying Su,Lina Ding,Hege G. Russnes,Andrea L. Richardson,Kirsten Babski,Elizabeth Min Hui Kim,Charles H. McDonnell,Jon Wagner,Ron Rowberry,Gordon J. Freeman,Deborah Dillon,Therese Sorlie,Lisa M. Coussens,Judy E. Garber,Rong Fan,Kristie Bobolis,D. Craig Allred,Joon Jeong,So Yeon Park,Franziska Michor,Kornelia Polyak

DOI: https://doi.org/10.1158/2159-8290.22531790.v1

2023-01-01

Abstract:Supplementary Figure S1. Leukocyte frequencies in breast tissues. Supplementary Figure S2. Genes expressed in T cells. Supplementary Figure S3. Activity status of T cells. Supplementary Figure S4. TCR clonotypes in breast tissues. Supplementary Figure S5. Functional state of T cells. Supplementary Figure S6. Tumor topology. Supplementary Figure S7. Immune-related amplicons in breast cancer.
Supplementary Figure S3 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Linlin Yan,Mingming Wu,Tianyu Wang,Hui Yuan,Xiao Zhang,Huafeng Zhang,Tao Li,Vijay Pandey,Xinghua Han,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.25603300

2024-01-01

Abstract:Supplementary Figure S3 shows that MIF is identified as a key cytokine secreted by BCSC.
Supplementary Figure S6 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Linlin Yan,Mingming Wu,Tianyu Wang,Hui Yuan,Xiao Zhang,Huafeng Zhang,Tao Li,Vijay Pandey,Xinghua Han,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.25731633.v1

2024-01-01

Abstract:Supplementary Figure S6 shows that BCSCs regulate cancer cell metabolic reprogramming through ALDOC.
Supplementary Figure S8 from CD24<sup>hi</sup>CD27<sup>+</sup> Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Huanhuan Huang,Yao,Lin Shen,Jingxin Jiang,Ting Zhang,Jia Xiong,Jiaxin Li,Shanshan Sun,Siwei Zheng,Fang Jia,Jun Zhou,Xiuyan Yu,Wuzhen Chen,Jun Shen,Wenjie Xia,Xuan Shao,Qingqing Wang,Jian Huang,Chao Ni

DOI: https://doi.org/10.1158/1078-0432.24826140.v1

2023-01-01

Abstract:Fig. S8. Depletion of B cells within the LNs of mice by anti-CD20 antibody injection.
Supplementary Figure S2 from CD24hiCD27+ Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Huanhuan Huang,Yao,Lesang Shen,Jingxin Jiang,Ting Zhang,Jia Xiong,Jiaxin Li,Shanshan Sun,Siwei Zheng,Fang Jia,Jun Zhou,Xiuyan Yu,Wuzhen Chen,Jun Shen,Wenjie Xia,Xuan Shao,Qingqing Wang,Jian Huang,Chao Ni

DOI: https://doi.org/10.1158/1078-0432.24826164

2023-01-01

Abstract:Fig. S2. Comparison of CD24hiCD27+ Bregs from peripheral blood and LNs.
Supplementary Figure 6 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Nadire Duru,Ming Fan,Demet Candas,Cheikh Menaa,Hsin-Chen Liu,Danupon Nantajit,Yunfei Wen,Kai Xiao,Angela Eldridge,Brett A. Chromy,Shiyong Li,Douglas R. Spitz,Kit S. Lam,Max S. Wicha,Jian

DOI: https://doi.org/10.1158/1078-0432.22451720

2023-01-01

Abstract:PDF file - 540K, Protein profiling analysis of HER2+ versus HER2- BCSCs
Supplementary Figure S8 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Linlin Yan,Mingming Wu,Tianyu Wang,Hui Yuan,Xiao Zhang,Huafeng Zhang,Tao Li,Vijay Pandey,Xinghua Han,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.25607415.v1

2024-01-01

Abstract:Supplementary Figure S8 shows that Targeting MIF enhances cancer cell sensitivity to immune cell killing.
Supplementary Figure 4 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Nadire Duru,Ming Fan,Demet Candas,Cheikh Menaa,Hsin-Chen Liu,Danupon Nantajit,Yunfei Wen,Kai Xiao,Angela Eldridge,Brett A. Chromy,Shiyong Li,Douglas R. Spitz,Kit S. Lam,Max S. Wicha,Jian

DOI: https://doi.org/10.1158/1078-0432.22451726

2023-01-01

Abstract:PDF file - 89K, Enhanced gap filling rates in HER2+ versus HER2- BCSCs
Supplementary Figure 3 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Nadire Duru,Ming Fan,Demet Candas,Cheikh Menaa,Hsin-Chen Liu,Danupon Nantajit,Yunfei Wen,Kai Xiao,Angela Eldridge,Brett A. Chromy,Shiyong Li,Douglas R. Spitz,Kit S. Lam,Max S. Wicha,Jian

DOI: https://doi.org/10.1158/1078-0432.22451729

2023-01-01

Abstract:PDF file - 144K, FACS of irradiated MCF7 cells and xenograft tumors
The Influence of Mir-34A Expression on Stemness and Cytotoxic Susceptibility of Breast Cancer Stem Cells

Hongyao Zhang,Ning Li,Jiahui Zhang,Fengjiao Jin,Meihua Shan,Junfang Qin,Yue Wang

DOI: https://doi.org/10.1080/15384047.2016.1177678

2016-01-01

Cancer Biology & Therapy

Abstract:In this study, we investigate the effect of miR-34a expression and biological characteristics of breast cancer stem cells (BCSCs). The mammospheres were formed from murine breast cancer cell line 4T1 and regarded as murine BCSCs. Identification of stemness molecules and cloning experiments validate the biological characteristics of BCSCs we have established. We showed that miR-34a, as a tumor suppressor, could separately reduce the stemness of BCSCs and activate the cytotoxic susceptibility of BCSCs to natural killer (NK) cells in vitro via down regulating the expression of Notch1 signaling molecules. Moreover, miR-34a could completely restrain established mice breast tumor xenografts in vivo in the NOD/SCID mice that have functional NK cells at a normal level, whereas it was less effective in NOD/SCID/ CD122/IL-2Rβ mice that do not have functional NK cells. We conclude that miR-34a is a crucial, dual tumor suppressor and BCSCs-targeting immunotherapeutic agent and has shown efficacy in the treatment of murine breast cancer. The results also suggest that impaired NK cells could contribute to the resistance to therapies.
Supplementary Figure S7 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Linlin Yan,Mingming Wu,Tianyu Wang,Hui Yuan,Xiao Zhang,Huafeng Zhang,Tao Li,Vijay Pandey,Xinghua Han,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.25731630

2024-01-01

Abstract:Supplementary Figure S7 shows that MIF is associated with immunosuppressive Tumor microenvironment.

Supplementary Figure 2 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure 3 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure 6 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure 7 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure 5 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure 1 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Text from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure S2 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Supplementary Tables 1 - 10 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure S4 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Supplementary Figures 1 Through 7, Supplementary Methods from Immune Escape in Breast Cancer During in Situ to Invasive Carcinoma Transition

Supplementary Figure S3 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Supplementary Figure S6 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Supplementary Figure S8 from CD24&lt;sup&gt;hi&lt;/sup&gt;CD27&lt;sup&gt;+&lt;/sup&gt; Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Supplementary Figure S2 from CD24hiCD27+ Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

Supplementary Figure 6 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure S8 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Supplementary Figure 4 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 3 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

The Influence of Mir-34A Expression on Stemness and Cytotoxic Susceptibility of Breast Cancer Stem Cells

Supplementary Figure S7 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

Supplementary Figure S8 from CD24<sup>hi</sup>CD27<sup>+</sup> Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer